Vicus Capital reduced its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 35.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 8,877 shares of the biopharmaceutical company’s stock after selling 4,940 shares during the period. Vicus Capital’s holdings in Pfizer were worth $256,000 […]
Signaturefd LLC cut its position in Pfizer Inc. (NYSE:PFE – Free Report) by 35.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 93,357 shares of the biopharmaceutical company’s stock after selling 51,510 shares during the period. Signaturefd LLC’s holdings in Pfizer […]
Klingenstein Fields & Co. LP lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 322,140 shares of the biopharmaceutical company’s stock after selling 9,340 shares during the quarter. […]
PSI Advisors LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 19.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 29,508 shares of the biopharmaceutical company’s stock after acquiring an additional 4,729 shares during the period. PSI Advisors LLC’s holdings in Pfizer […]
Brendel Financial Advisors LLC acquired a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 99,131 shares of the biopharmaceutical company’s stock, valued at approximately $2,854,000. Pfizer accounts for approximately 1.9% of Brendel Financial […]